In vitro cell culture of patient derived malignant pleural and peritoneal effusions for personalised drug screening

Table 1 Cohort description

Case	Location	Age	Sex	Tumour type	Diagnostic markers	Volume (ml)	Cell count (M/ml)	Drug test
1	Pleura	60	Male	GIT-Ca	CDX2+	45	2.3	No
2	Pleura	56	Male	Melanoma	Melan-A+	2600	2.5	No
3	Pleura	71	Female	GIT-Ca	CDX2+	2000	4.2	No
4	Ascites	67	Male	GIT-Ca	CDX2+	1800	0.6	No
5	Ascites	46	Female	Breast-Ca	ER+	600	6	No
6	Ascites	68	Female	Melanoma	Melan-A−, S100+	2000	1.4	No
7	Pleura	43	Male	GIT-Ca	CDX2+	1200	0.38	No
8	Pleura	92	Male	LADC	TTF-1+	800	0.38	No
9	Pleura	54	Female	LADC	TTF-1+	1600	0.03	Yes
10	Ascites	68	Female	Ovarian-Ca	ER+	2500	0.08	Yes
11	Pleura	43	Female	Ovarian-Ca	ER+	1100	0.12	Yes
12	Pleura	72	Male	LADC	TTF1−	1500	0.5	Yes
13	Pleura	65	Female	Breast-Ca	ER+	2000	0.4	Yes

TTF-1 thyroid transcription factor 1, ER estrogen receptor, LADC lung adenocarcinoma, Breast-Ca breast carcinoma, Ovarian-Ca ovarian carcinoma, GIT-Ca gastrointestinal carcinoma, + positive, − negative

ISSN: 1479-5876